pimagedine has been researched along with pyruvic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gillies, MC; Naidoo, D; Salonikas, C; Simpson, JM; Stayt, J; Su, T | 1 |
Cunningham, AM; Loske, C; Münch, G; Neumann, A; Nichol, K; Riederer, P; Schinzel, R | 1 |
Kim, SU; McLarnon, JG; Ryu, JK | 1 |
3 other study(ies) available for pimagedine and pyruvic acid
Article | Year |
---|---|
Effect of high glucose on permeability of retinal capillary endothelium in vitro.
Topics: Animals; Blood-Retinal Barrier; Capillary Permeability; Carbon Radioisotopes; Cattle; Cells, Cultured; Diffusion Chambers, Culture; Electric Impedance; Endothelium, Vascular; Enzyme Inhibitors; Fructose; Glucose; Guanidines; Inulin; Lactic Acid; Phthalazines; Polymers; Pyruvic Acid; Retinal Vessels; Sorbitol | 1997 |
Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress.
Topics: Animals; Antioxidants; Cell Death; Cell Line; Cricetinae; Enzyme Inhibitors; Fibroblasts; Glycation End Products, Advanced; Guanidines; Humans; Ketoglutaric Acids; Neuroblastoma; Oxidative Stress; Pyruvic Acid; Serum Albumin, Bovine | 1998 |
Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
Topics: Animals; Disease Models, Animal; Drug Administration Routes; Enzyme Inhibitors; Guanidines; Huntington Disease; Lactic Acid; Male; Neostriatum; Neuroglia; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques; Tyrosine | 2004 |